山东大学耳鼻喉眼学报 ›› 2020, Vol. 34 ›› Issue (3): 88-94.doi: 10.6040/j.issn.1673-3770.1.2020.039
吕静荣,陈淳,马衍,谢晋
Jingrong, CHEN Chun, MA Yan, XIE Jin
摘要: 目的 近年来,儿童甲状腺癌发病率不断上升,因此探讨儿童分化型甲状腺癌(children differentiated thyroid cancer,DTC)的临床特征并分析复发病例情况。 方法 回顾性分析1998年1月~2018年5月在上海交通大学医学院附属新华医院就诊的年龄≤13岁的50例儿童分化型甲状腺癌的临床资料。以7岁为界分为学龄前期组(≤7周岁)和学龄期组(>7周岁至13周岁),比较学龄前期与学龄期的临床特征情况。根据儿童DTC复发与否进行分组,比较复发组与无复发组的临床特征数据。比较临床特征、TNM分期及AJCC推荐的风险水平、复发及转移情况。采用Kaplan-Meier评价各年龄组无复发生存率。 结果 50例中,学龄前期与学龄期在局部侵犯情况有显著统计学差异(P=0.008),学龄前期组的局部侵犯比例(6例,42.6%)高于学龄期组(3例,8.1%)。两组肿瘤T分期存在明显差异(χ2=12.584,P=0.028),学龄期组T2比例较高(19例,51.4%),而学龄前期组T4a比例较高(5例,38.5%)。手术并发症比例,学龄前期组显著多与学龄期儿童(χ2=9.632,P=0.008)。无发复组双侧甲状腺全切比例明显高于复发组(85.7%,53.3%)(χ2=11.227,P=0.004),甲状腺全切可以降低儿童DTC复发风险。复发组与无复发组TNM与风险水平无统计学差异。复发组T1a、T1b和T2的总百分比超过50%,低风险水平为37.5%,中风险水平25%。约半数的复发病例在最初诊断时是TNM分期较低的且为低风险水平的。儿童DTC术后复发率差异无统计学意义(P>0.05)。 结论 学龄前期DTC病例的局部浸润,肿瘤分期以及手术并发症比例高于学龄期,年龄是儿童DTC的重要危险因素。将近一半的复发病例在最初诊断时是低风险的,因此应进一步研究儿童DTC复发风险评估策略。应提高对儿童DTC病例临床特征了解并采取适当的治疗策略。
中图分类号:
[1] Hogan AR, Zhuge Y, Perez EA, et al. Pediatric thyroid carcinoma: incidence and outcomes in 1753 patients[J]. J Surg Res, 2009, 156(1): 167-172. [2] Vergamini LB, Frazier AL, Abrantes FL, et al. Increase in the incidence of differentiated thyroid carcinoma in children, adolescents, and young adults: a population-based study[J]. J Pediatr, 2014, 164(6): 1481-1485. [3] Wu XC, Chen VW, Steele B, et al. Cancer incidence in adolescents and young adults in the United States, 1992-1997[J]. J Adolesc Health, 2003, 32(6): 405-415. [4] Liu L, Huang F, Liu B, et al. Detection of distant metastasis at the time of ablation in children with differentiated thyroid cancer: the value of pre-ablation stimulated thyroglobulin[J]. Journal of Pediatric Endocrinology and Metabolism, 2018, 31(7): 751-756. [5] Lazar L, Lebenthal Y, Steinmetz A, et al. Differentiated thyroid carcinoma in pediatric patients: comparison of presentation and course between pre-pubertal children and adolescents[J]. J Pediatr, 2009, 154(5): 708-714. [6] Hay ID, Gonzalez-Losada T, Reinalda M S, et al. Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008[J]. World journal of surgery, 2010, 34(6): 1192-1202. [7] Handkiewicz-Junak D, Wloch J, Roskosz J, et al. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer[J]. J Nucl Med, 2007, 48(6): 879-888. [8] Saraiva J, Ribeiro C, Melo M, et al. Thyroid carcinoma in children and young adults: retrospective review of 19 cases[J]. Acta Med Port, 2013, 26(5): 578-582. [9] Sugino K, Nagahama M, Kitagawa W, et al. Papillary Thyroid Carcinoma in Children and Adolescents: Long-Term Follow-Up and Clinical Characteristics[J]. World J Surg, 2015, 39(9): 2259-2265. [10] Kiratli PO, Volkan-Salanci B, Gunay EC, et al. Thyroid cancer in pediatric age group: an institutional experience and review of the literature[J]. J Pediatr Hematol Oncol, 2013, 35(2): 93-97. [11] Markovina S, Grigsby PW, Schwarz JK, et al. Treatment approach, surveillance, and outcome of well-differentiated thyroid cancer in childhood and adolescence[J]. Thyroid, 2014, 24(7): 1121-1126. [12] Lamartina L, Grani G, Arvat E, et al. 8th edition of AJCC/TNM staging system of thyroid cancer: what to expect[J]. Endocrine Related Cancer, 2018, 25(3): L7-L11. [13] 胡亚美, 江申沈, 倪鑫, 等. 诸福棠实用儿科学[M]. 第8版. 北京: 人民卫生出版社, 2015. [14] Rivkees SA, Mazzaferri EL, Verburg FA, et al. The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy[J]. Endocr Rev, 2011, 32(6): 798-826. [15] Alzahrani AS, Alkhafaji D, Tuli M, et al. Comparison of differentiated thyroid cancer in children and adolescents(=20 years)with young adults[J]. Clin Endocrinol(Oxf), 2016, 84(4): 571-577. [16] Al-Qahtani KH, Tunio MA, Al Asiri M, et al. Clinicopathological features and treatment outcomes of differentiated thyroid cancer in Saudi children and adults[J]. J Otolaryngol Head Neck Surg, 2015, 44: 48. [17] 贺青卿,庄大勇,魏金祥. 甲状腺乳头状癌外科治疗策略[J]. 山东大学耳鼻喉眼学报, 2011, 25(5): 7-10. [18] 余济春. 分化型甲状腺癌颈淋巴结清扫术[J]. 山东大学耳鼻喉眼学报, 2016, 30(2): 10-12. [19] Francis GL, Waguespack SG, Bauer AJ, et al. Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer[J]. Thyroid, 2015, 25(7): 716-759. [20] 李树春, 李振东, 刘宏伟, 等. 青少年及儿童分化型甲状腺癌临床特征及治疗策略[J]. 临床耳鼻咽喉头颈外科杂志, 2017, 31(6): 431-437. [21] 秦晓山, 张浩, 张平, 等. 儿童及青少年分化型甲状腺癌75例临床分析[J]. 中华内分泌外科杂志, 2019, 13(4): 301-304. [22] Wada N, Sugino K, Mimura T, et al. Pediatric differentiated thyroid carcinoma in stage I: risk factor analysis for disease free survival[J]. BMC Cancer, 2009, 9(1): 306. [23] O'gorman CS, Hamilton J, Rachmiel M, et al. Thyroid cancer in childhood: a retrospective review of childhood course[J]. Thyroid, 2010, 20(4): 375-380. [24] Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM[J]. Ann Surg Oncol, 2010, 17(6): 1471-1474. [25] Demidchik YE, Saenko VA, Yamashita S. Childhood thyroid cancer in Belarus, Russia, and Ukraine after Chernobyl and at present[J]. Arq Bras Endocrinol Metabol, 2007, 51(5): 748-762. [26] Livhits MJ, Pasternak JD, Xiong M, et al. Pre-Ablation Thyroglobulin and Thyroglobulin to Thyroid-Stimulating Hormone Ratio May Be Associated with Pulmonary Metastases in Children with Differentiated Thyroid Cancer[J]. Endocr Pract, 2016, 22(11): 1259-1266. [27] Joseph KR, Edirimanne S, Eslick GD. Multifocality as a prognostic factor in thyroid cancer: A meta-analysis[J]. Int J Surg, 2018, 50: 121-125. [28] Vuong HG, Duong UNP, Pham TQ, et al. Clinicopathological Risk Factors for Distant Metastasis in Differentiated Thyroid Carcinoma: A Meta-analysis[J]. World J Surg, 2018, 42(4): 1005-1017. |
[1] | 陈东彦,钱晔,魏东敏,李文明,夏同良,雷大鹏,潘新良. 高频超声诊断下咽鳞癌淋巴结转移的临床研究[J]. 山东大学耳鼻喉眼学报, 2022, 36(5): 18-23. |
[2] | 张丰珍, 王桂香, 魏沄沄, 张亚梅, 赵靖, 王华, 李宏彬, 李晓丹, 张杰. 合并轻度出血性疾病的扁桃体和(或)腺样体切除术患儿围手术期管理[J]. 山东大学耳鼻喉眼学报, 2022, 36(4): 66-72. |
[3] | 林一杭,李幼瑾. 肠道微生态在儿童变应性鼻炎中的研究现状[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 116-122. |
[4] | 李琳,高正文,崔楠,孙健平,黄贤明,崔静. 儿童慢性鼻窦炎基因表达谱的生物信息学分析[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 171-180. |
[5] | 鹿伟理,姜涛,李宪华. 多重致敏儿童变应性鼻炎患者sIgE特征分析[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 260-265. |
[6] | 杨扬, 王晓旭, 张杰. 儿童中耳胆脂瘤诊治进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(1): 1-6. |
[7] | 高信忠, 林宗通, 沈翎, 刘平凡, 林兴, 许杨杨. 咽鼓管球囊扩张联合腺样体切除术治疗儿童分泌性中耳炎疗效分析[J]. 山东大学耳鼻喉眼学报, 2022, 36(1): 7-12. |
[8] | 马宁, 陈敏, 刘薇, 杨扬, 邵剑波, 郝津生, 刘冰, 张晓, 段晓岷, 张祺丰, 张杰. 儿童颞骨骨折临床特点和治疗策略[J]. 山东大学耳鼻喉眼学报, 2022, 36(1): 13-19. |
[9] | 胡春燕, 党攀红, 张睿, 樊孟耘. 儿童单侧感音性听力损失的听力学及影像学特征149例分析[J]. 山东大学耳鼻喉眼学报, 2022, 36(1): 31-36. |
[10] | 党攀红, 张睿, 胡春燕, 王洁, 樊孟耘. 儿童乳突-颞下迷路外面神经减压术8例临床分析[J]. 山东大学耳鼻喉眼学报, 2022, 36(1): 37-42. |
[11] | 刘珊珊, 韩书婧, 王晓旭, 李艳红, 倪鑫, 张杰. 儿童细菌性脑膜炎后听力损害危险因素的系统评价与Meta分析[J]. 山东大学耳鼻喉眼学报, 2022, 36(1): 48-54. |
[12] | 焦雪梅,杨扬,李春凤,张晓琳. 鼓膜置管对分泌性中耳炎患儿咽鼓管功能的影响[J]. 山东大学耳鼻喉眼学报, 2022, 36(1): 60-63. |
[13] | 王蓬鹏,葛文彤,唐力行,杨小健,张薇,肖潇,韩阳. 开放性鼻整形切口治疗儿童先天性鼻中线囊肿及瘘管4例及文献复习[J]. 山东大学耳鼻喉眼学报, 2022, 36(1): 64-69. |
[14] | 李孟辉,郅莉莉,戚凯文,王珊珊,高倩,步美玲,姜荷云,冯绛楠,王金荣. 皮下免疫治疗对单一尘螨和合并霉菌过敏儿童哮喘的临床研究[J]. 山东大学耳鼻喉眼学报, 2022, 36(1): 75-80. |
[15] | 赵海涛, 王亚芳, 赫莉, 陈文静, 邢民者, 郑文娟,阎玉彦,刘晓峰. 可视喉镜在先天性舌根囊肿患儿手术麻醉中的应用[J]. 山东大学耳鼻喉眼学报, 2022, 36(1): 106-110. |
|